Patients' clinical antibiotic treatment of deep II degree burns usually fails to achieve the ideal effect; in order to avoid the late result in pigmentation, scarring, and even limb dysfunction, it also needs to deal effectively with burn wounds.
The purpose of this study is to evaluate nanosilver dressing in treating deep II degree burn wound infection in patients with clinical studies.
106 burn patients were classified into the Sulfadiazine Silver Cream (SSC) group ( n = 53) and the Nanosilver Burn Dressing (NSBD) group ( n = 53). Both of them received basic wound treatment, and wound healing time and pigmentation fading away time of all patients were recorded. And the wound healing rate of the patients was calculated. Serum levels of tumor necrosis factor alpha (TNF- α) and interleukin-1beta (IL-1 β) were detected pre- and posttreatment.
After basic treatment for all patients, Sulfadiazine Silver Cream was used in the SSC group, and Nanosilver Burn Dressing was used in the NSBD group. It was observed that after treatment, compared with the SSC group, there was significant efficiency; wound healing rate, healing time, and pigmentation fading away time were shortened in the NSBD group, and IL-1 β levels were decreased, and the positive rate of bacterial culture was decreased (all P < 0.05).